Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
LA JOLLA PHARMACEUTICAL CO (LJPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 9.3% stake in La Jolla Pharmaceutical Company |
| 07/12/2021 |
SC 13G/A
| BlackRock Inc. reports a 1.4% stake in LA JOLLA PHARMACEUTICAL CO |
| 02/12/2021 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 8.8% stake in LA JOLLA PHARMACEUTICAL CO |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 5.4% stake in LA JOLLA PHARMACEUTICAL CO |
| 01/04/2021 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in La Jolla Pharmaceutical Company |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 9.4% stake in La Jolla Pharmaceutical Company |
| 02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 9.9% stake in La Jolla Pharmaceutical Company |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 4.6% stake in LA JOLLA PHARMACEUTICAL CO |
| 02/07/2020 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 0% stake in La Jolla Pharmaceutical Company |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 5.8% stake in LA JOLLA PHARMACEUTICAL CO |
| 12/10/2019 |
SC 13G/A
| FMR LLC reports a 6.9% stake in LA JOLLA PHARMACEUTICAL CO |
| 04/10/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 1.8% stake in La Jolla Pharmaceutical Company |
| 02/14/2019 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 2% stake in La Jolla Pharmaceutical Company |
| 02/14/2019 |
SC 13G/A
| Consonance Capital Management LP reports a 12% stake in LA JOLLA PHARMACEUTICAL CO |
| 02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 7.4% stake in La Jolla Pharmaceutical Company |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/11/2019 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 8.6% stake in La Jolla Pharmaceutical Company |
| 04/06/2018 |
SC 13G/A
| BlackRock Inc. reports a 4.6% stake in LA JOLLA PHARMACEUTICAL CO |
| 02/14/2018 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 6% stake in La Jolla Pharmaceutical Company |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 15% stake in LA JOLLA PHARMACEUTICAL CO |
| 02/07/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in LA JOLLA PHARMACEUTICAL COMPANY |
| 02/06/2018 |
SC 13G/A
| JANUS CAPITAL MANAGEMENT LLC reports a 0% stake in LA JOLLA PHARMACEUTICAL COMPANY |
| 01/26/2018 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC reports a 10.9% stake in LA JOLLA PHARMACEUTICAL COMPANY |
| 01/11/2018 |
SC 13G/A
| Broadfin Capital, LLC reports a 4.6% stake in La Jolla Pharmaceutical Company |
| 12/18/2017 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 15.3% stake in La Jolla Pharmaceutical Company |
| 02/15/2017 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 7.4% stake in La Jolla Pharmaceutical Company |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|
|